Issuer directory · Other Health Care
Other Health Care: private offerings on SEC Form D.
882 issuers in this group filed a Form D since 2024, reported at least $1 million sold, and either raised from ten or more investors or amended the notice at least once. Ranked by the amount reported sold on the newest notice, 100 to a page. The platform column names the AltStreet-reviewed platform an issuer belongs to; "direct" means none is on record.
| Issuer | Reported sold | Investors | Exemption | Newest notice | Filings | Platform |
|---|---|---|---|---|---|---|
| Fovea Investment Holdings, LLC | $800.0M | 146 | 506(b) | Jan 17, 2025 | 1 | direct |
| Radiology Partners Holdings, LLC | $719.8M | 7 | 506(b) | Mar 7, 2024 | 1 | direct |
| Waystar Holding Corp. | $620.8M | 102 | 506(b) | Oct 10, 2025 | 1 | direct |
| Transcarent, Inc. | $481.0M | 33 | 506(b) | Apr 22, 2025 | 1 | direct |
| ROM Technologies, Inc. | $448.1M | 3,556 | 506(c) | Feb 19, 2026 | 4 | direct |
| Sharps Technology Inc. | $410.9M | 62 | 506(b) | Oct 31, 2025 | 1 | direct |
| Monogram Health Holdings, Inc. | $374.0M | 16 | 506(b) | Jan 9, 2023 | 1 | direct |
| CP Venture II, LP | $349.0M | 2 | 506(b) | Jun 27, 2024 | 1 | direct |
| Mirador Therapeutics, Inc. | $333.0M | 31 | 506(b) | Apr 3, 2024 | 1 | direct |
| United Digestive Holdings, LLC | $323.3M | 105 | 506(b) | Apr 14, 2023 | 1 | direct |
| Precision Neuroscience Corp | $250.0M | 46 | 506(b) | Sep 28, 2026 | 1 | direct |
| RICHMOND BUYER L.P. | $232.6M | 205 | 506(b) | Sep 26, 2024 | 1 | direct |
| ZIMMER BIOMET HOLDINGS, INC. | $216.1M | 157 | 506(b) | Feb 15, 2023 | 1 | direct |
| HeartFlow Holding, Inc. | $215.9M | 40 | 506(b) | Apr 24, 2023 | 1 | direct |
| Candid Therapeutics, Inc. | $206.2M | 33 | 506(b) | Sep 13, 2024 | 1 | direct |
| Opry Investment Holdings I, LLC | $202.7M | 15 | 506(b) | Aug 8, 2023 | 2 | direct |
| Cognito Therapeutics Group, Inc. | $196.3M | 23 | 506(b) | Apr 1, 2025 | 1 | direct |
| MAIN STREET RURAL, INC. | $189.9M | 43 | 506(b) | Dec 29, 2023 | 1 | direct |
| Rightway Healthcare, Inc. | $155.0M | 6 | 506(b) | Sep 8, 2026 | 1 | direct |
| INSIGHTEC LTD | $150.0M | 39 | 506(b) | Jun 28, 2024 | 1 | direct |
| Saluda Medical, Inc. | $150.0M | 18 | 506(b) | Apr 17, 2023 | 1 | direct |
| Veradermics, Inc | $135.0M | 40 | 506(b) | Oct 28, 2025 | 1 | direct |
| Endogenex, Inc. | $132.4M | 16 | 506(b) | Nov 6, 2026 | 2 | direct |
| Ember Management Aggregator, L.P. | $130.8M | 59 | 506(b) | Jun 4, 2026 | 4 | direct |
| EVMS Holdco, LLC | $129.8M | 5 | 506(b) | May 27, 2026 | 1 | direct |
| Employee Health Holdings, LP | $127.6M | 52 | 506(b) | Jul 31, 2026 | 2 | direct |
| Halda Therapeutics, LLC | $126.5M | 20 | 506(b) | Aug 12, 2024 | 1 | direct |
| CP Venture IV, LP | $126.2M | 1 | 506(b) | Dec 19, 2025 | 1 | direct |
| Allotera Therapeutics, Inc. | $123.3M | 20 | 506(b) | Jul 23, 2026 | 2 | direct |
| Supira Medical, Inc. | $120.0M | 20 | 506(b) | Apr 3, 2025 | 1 | direct |
| SetPoint Medical Corp | $115.5M | 24 | 506(b) | Oct 28, 2025 | 2 | direct |
| Nalu Medical, Inc. | $115.1M | 29 | 506(b) | Oct 9, 2024 | 3 | direct |
| CORTICA INC. | $114.7M | 21 | 506(b) | Oct 2, 2023 | 2 | direct |
| Imperative Care, Inc. | $111.3M | 15 | 506(b) | Jul 10, 2026 | 2 | direct |
| Cognito Therapeutics Ltd. | $108.8M | 13 | 506(b) | Nov 15, 2023 | 2 | direct |
| RENOVARO INC. | $106.8M | 8 | 506(b) | Feb 23, 2024 | 1 | direct |
| RefleXion Medical, Inc. | $106.7M | 43 | 506(b) | Nov 22, 2023 | 1 | direct |
| Vignette Bio, Inc. | $105.0M | 56 | 506(b) | Sep 13, 2024 | 1 | direct |
| Candid Group, Inc. | $104.9M | 12 | 506(b) | Jul 22, 2026 | 1 | direct |
| HistoSonics, Inc. | $102.0M | 39 | 506(b) | Aug 15, 2024 | 1 | direct |
| JenaValve Technology Inc | $100.4M | 17 | 506(b) | Apr 8, 2024 | 3 | direct |
| TherapyMatch, Inc. | $100.0M | 9 | 506(b) | Jul 31, 2024 | 1 | direct |
| Beta Bionics, Inc | $99.5M | 29 | 506(b) | Sep 15, 2023 | 1 | direct |
| Elevate Care International Topco LP | $98.4M | 16 | 506(b) | Nov 14, 2023 | 1 | direct |
| Thyme Care, Inc. | $97.0M | 14 | 506(b) | Sep 25, 2025 | 1 | direct |
| Harbor Health Team Inc. | $95.9M | 16 | 506(b) | Jan 23, 2024 | 1 | direct |
| ByHeart, Inc. | $95.5M | 46 | 506(b) | May 7, 2026 | 3 | direct |
| GYNESONICS, INC | $92.2M | 13 | 506(b) | Nov 6, 2023 | 2 | direct |
| Proxima Bio, Inc. | $91.5M | 11 | 506(b) | Jun 10, 2026 | 2 | direct |
| Color Holdings, L.P. | $90.9M | 35 | 506(b) | Aug 11, 2023 | 1 | direct |
| Alleviant Medical, Inc. | $90.8M | 12 | 506(b) | Jan 27, 2025 | 1 | direct |
| TRC 2004, Inc. | $90.0M | 30 | 506(b) | Sep 13, 2024 | 1 | direct |
| Fountain Life, LLC | $87.1M | 61 | 506(b) | Mar 11, 2025 | 2 | direct |
| BioDerm Holdings, LP | $85.4M | 32 | 506(c) | Feb 6, 2023 | 1 | direct |
| Averna Therapeutics Inc. | $85.0M | 13 | 506(b) | Mar 20, 2026 | 3 | direct |
| Prenuvo, Inc. | $85.0M | 13 | 506(b) | Feb 14, 2025 | 1 | direct |
| RESTOR3D, Inc. | $84.8M | 133 | 506(b) | Aug 22, 2025 | 1 | direct |
| BRIDGE TO LIFE LTD | $82.5M | 12 | 506(b) | Oct 21, 2026 | 1 | direct |
| Apreo Health, Inc. | $81.8M | 7 | 506(b) | Aug 19, 2025 | 1 | direct |
| Willow Innovations, Inc. | $81.4M | 30 | 506(b) | Jan 22, 2024 | 1 | direct |
| Alpfa Medical, Inc. | $80.3M | 71 | 506(b) | Sep 28, 2026 | 1 | direct |
| American Pain Consortium Holdings, LLC | $79.7M | 11 | 506(b) | Dec 4, 2023 | 1 | direct |
| Ensysce Biosciences, Inc. | $77.2M | 44 | 506(b) | Aug 20, 2026 | 1 | direct |
| RMX Holdco, Inc. | $76.6M | 5 | 506(b) | Jan 11, 2024 | 2 | direct |
| Genome Medical Holding Co | $75.3M | 14 | 506(b) | Sep 23, 2024 | 1 | direct |
| OneOncology Management Holdco, LLC | $75.2M | 41 | 506(b) | Jun 26, 2023 | 1 | direct |
| iSchemaView, Inc. | $75.0M | 5 | 506(b) | Aug 14, 2026 | 4 | direct |
| SpyGlassPharma, Inc. | $75.0M | 10 | 506(b) | Jun 5, 2025 | 1 | direct |
| ECPH, LLC | $74.6M | 277 | 506(b) | May 14, 2026 | 5 | direct |
| R3 Vascular Inc. | $72.5M | 34 | 506(b) | Sep 12, 2024 | 1 | direct |
| Kindbody, Inc. | $66.2M | 41 | 506(b) | May 4, 2023 | 2 | direct |
| Truepill, Inc. | $66.2M | 14 | 506(b) | Sep 1, 2023 | 1 | direct |
| Nucleus Radiopharma, Inc. | $66.1M | 12 | 506(b) | Apr 11, 2024 | 1 | direct |
| Wellvana Health, LLC | $64.5M | 13 | 506(b) | Mar 10, 2023 | 1 | direct |
| Veridian Healthcare Holdings LLC | $63.0M | 12 | 506(b) | Sep 8, 2023 | 1 | direct |
| Moximed, Inc | $62.7M | 35 | 506(b) | Aug 20, 2024 | 1 | direct |
| Dror Ortho-Design, Inc. | $62.2M | 39 | 506(b) | Sep 18, 2023 | 1 | direct |
| Concept Medical, Inc. | $60.0M | 1 | 506(b) | Apr 24, 2026 | 1 | direct |
| Fourth Edge LLC | $60.0M | 1 | 506(b) | Dec 12, 2025 | 1 | direct |
| BAMF Health Parent, Inc. | $59.7M | 12 | 506(b) | May 19, 2026 | 1 | direct |
| InfoBionic, Inc. | $57.8M | 30 | 506(b) | Oct 11, 2023 | 1 | direct |
| Procyrion, Inc. | $57.7M | 24 | 506(b) | Feb 5, 2024 | 1 | direct |
| CodaMetrix Inc. | $57.4M | 12 | 506(b) | Mar 21, 2023 | 1 | direct |
| Belong Health, Inc. | $57.0M | 7 | 506(b) | Jul 11, 2025 | 1 | direct |
| Avive Solutions, Inc. | $56.7M | 114 | 506(b) | Apr 18, 2024 | 2 | direct |
| Centaur Health Holdings, Inc. | $56.5M | 67 | 506(b) | Jun 11, 2025 | 3 | direct |
| Allied Health MSO Holdco, LLC | $56.4M | 65 | 506(b) | Sep 27, 2024 | 3 | direct |
| Women's and Children's Health Technology EU Fund II SCSp | $56.4M | 9 | 506(b) | Aug 11, 2026 | 1 | direct |
| Accompany Health, Inc. | $56.3M | 13 | 506(b) | Feb 2, 2024 | 1 | direct |
| Diana Health, Inc. | $55.4M | 7 | 506(b) | Sep 8, 2025 | 1 | direct |
| Equip Health, Inc. | $54.1M | 12 | 506(b) | Sep 16, 2025 | 2 | direct |
| GT MEDICAL TECHNOLOGIES, INC. | $53.3M | 37 | 506(b) | Jun 11, 2025 | 2 | direct |
| Grow Care, Inc. | $52.5M | 1 | 506(b) | Apr 19, 2024 | 1 | direct |
| Diverge Health, Inc. | $52.4M | 22 | 506(b) | Oct 31, 2024 | 1 | direct |
| XO Health Inc. | $52.2M | 49 | 506(b) | Sep 4, 2025 | 1 | direct |
| Hometeam Technologies, Inc. | $51.8M | 26 | 506(b) | Mar 13, 2024 | 1 | direct |
| Akura Medical, Inc. | $51.4M | 20 | 506(b) | Dec 3, 2025 | 1 | direct |
| Elephas Biosciences Corp | $51.2M | 10 | 506(b) | Jan 9, 2024 | 1 | direct |
| Route 92 Medical, Inc. | $50.4M | 5 | 506(b) | Jul 12, 2024 | 1 | direct |
| Paradromics, Inc. | $50.1M | 53 | 506(b) | Nov 7, 2023 | 2 | direct |
Source: SEC EDGAR Form D and D/A filings. A Form D is a notice of an exempt offering; the SEC does not review or approve the offering. Reported figures are the issuer's own. Other groups: the full directory.
